Total Payments
$34,046
2024 Payments
$37.81
Companies
34
Transactions
310
Medicare Patients
2,945
Medicare Billing
$364,877
Payment Breakdown by Category
Other$25,875 (76.0%)
Food & Beverage$5,805 (17.0%)
Travel$2,354 (6.9%)
Education$11.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,875 | 15 | 76.0% |
| Food and Beverage | $5,805 | 283 | 17.0% |
| Travel and Lodging | $2,354 | 11 | 6.9% |
| Education | $11.77 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $25,377 | 123 | $0 (2024) |
| Allergan Inc. | $5,744 | 26 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $609.00 | 41 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $287.55 | 22 | $0 (2023) |
| Covidien LP | $247.99 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $214.42 | 15 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $182.61 | 13 | $0 (2020) |
| Endogastric Solutions, Inc | $160.77 | 6 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2019) |
| PFIZER INC. | $118.44 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.81 | 2 | ABBVIE INC. ($22.06) |
| 2023 | $355.66 | 12 | Medtronic, Inc. ($81.91) |
| 2022 | $336.27 | 14 | ABBVIE INC. ($192.60) |
| 2021 | $2,713 | 27 | AbbVie Inc. ($2,380) |
| 2020 | $2,691 | 31 | AbbVie Inc. ($2,382) |
| 2019 | $6,015 | 77 | AbbVie, Inc. ($5,067) |
| 2018 | $9,536 | 68 | AbbVie, Inc. ($8,996) |
| 2017 | $12,361 | 79 | AbbVie, Inc. ($6,295) |
All Payment Transactions
310 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Gastroenterology | ||||||
| 10/18/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: GI | ||||||
| 08/23/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/31/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: CNS | ||||||
| 06/24/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Immunology | ||||||
| 05/23/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: GI | ||||||
| 04/20/2023 | Cook Medical LLC | FUSION QUATTRO (Device) | Food and Beverage | Cash or cash equivalent | $53.82 | General |
| Category: Endoscopy | ||||||
| 02/21/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $71.33 | General |
| Category: General - Biliary Devices_ENDO | ||||||
| 01/19/2023 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $81.91 | General |
| Category: Motility Testing | ||||||
| 06/03/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: IMMUNOLOGY | ||||||
| 05/27/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: VIROLOGY | ||||||
| 05/20/2022 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: GERD | ||||||
| 05/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: IMMUNOLOGY | ||||||
| 03/24/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/23/2022 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $21.82 | General |
| Category: GERD | ||||||
| 03/21/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Immunology | ||||||
| 03/07/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/01/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2022 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $71.78 | General |
| Category: GERD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 674 | 710 | $576,385 | $89,136 |
| 2022 | 14 | 709 | 750 | $531,125 | $86,583 |
| 2021 | 14 | 717 | 751 | $460,898 | $85,548 |
| 2020 | 14 | 845 | 904 | $482,990 | $103,611 |
Total Patients
2,945
Total Services
3,115
Medicare Billing
$364,877
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 133 | 135 | $169,044 | $27,004 | 16.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 215 | 224 | $172,901 | $16,505 | 9.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 85 | 85 | $60,072 | $14,551 | 24.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 56 | 56 | $37,431 | $9,807 | 26.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 66 | 76 | $47,608 | $7,981 | 16.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 31 | 32 | $21,555 | $4,127 | 19.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $21,830 | $2,701 | 12.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 22 | $14,550 | $2,055 | 14.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $4,751 | $1,916 | 40.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 28 | $4,380 | $1,716 | 39.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2023 | 11 | 11 | $22,263 | $772.38 | 3.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 113 | 114 | $138,282 | $22,043 | 15.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 229 | 234 | $139,422 | $17,746 | 12.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 65 | 65 | $44,590 | $11,341 | 25.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 66 | 70 | $42,490 | $7,426 | 17.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 37 | 37 | $24,013 | $6,503 | 27.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 44 | 44 | $31,276 | $6,120 | 19.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $25,920 | $2,417 | 9.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 42 | $6,384 | $2,269 | 35.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 26 | $4,446 | $2,011 | 45.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $4,617 | $1,941 | 42.0% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 12 | 12 | $11,340 | $1,841 | 16.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $12,105 | $1,811 | 15.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2022 | 20 | 22 | $43,054 | $1,745 | 4.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $3,186 | $1,369 | 43.0% |
About Dr. George Yared, M.D
Dr. George Yared, M.D is a Gastroenterology healthcare provider based in Tifton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790786226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Yared, M.D has received a total of $34,046 in payments from pharmaceutical and medical device companies, with $37.81 received in 2024. These payments were reported across 310 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,875).
As a Medicare-enrolled provider, Yared has provided services to 2,945 Medicare beneficiaries, totaling 3,115 services with total Medicare billing of $364,877. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Tifton, GA
- Active Since 08/09/2005
- Last Updated 03/08/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790786226
Products in Payments
- Creon (Drug) $8,913
- LINZESS (Drug) $5,666
- CREON (Drug) $2,478
- Humira (Biological) $447.44
- STELARA (Biological) $259.01
- XIFAXAN (Drug) $245.42
- Mavyret (Drug) $225.62
- Bravo (Device) $220.40
- Entyvio (Biological) $184.89
- Amitiza (Drug) $178.52
- ZEPATIER (Drug) $164.55
- ESOPHYX (Device) $160.77
- XELJANZ (Drug) $118.44
- HUMIRA (Biological) $109.76
- Linzess (Drug) $108.59
- VIBERZI (Drug) $108.59
- ENTYVIO (Biological) $104.55
- OCALIVA (Drug) $99.13
- CLENPIQ (Drug) $90.24
- RINVOQ (Biological) $83.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.